| Abstract | The 6th Annual Vaccines: All Things Considered conference was hosted by GTCbio. The purpose of the conference was to provide a forum for researchers from academia, industry and government ot update one another about novel vaccine developments, regulatory perspectives, new technologies and governemnt policies. The meeting was attended by approximately 80 delegates, many from European countries, and included two keynote addresses, 20 oral presentations and 15 poster presented over a 2-day period. As part of the conference's tradition, two posters were selected for oral presentation. This meeting report will highlight the main issues discussed. |
|---|
